NeuPath Health Inc.
NPTH.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 24.57% | 23.78% | 3.87% | 9.22% | 7.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.57% | 23.78% | 3.87% | 9.22% | 7.31% |
| Cost of Revenue | 23.41% | 24.16% | 3.45% | 9.26% | 7.27% |
| Gross Profit | 29.75% | 22.29% | 5.77% | 9.04% | 7.50% |
| SG&A Expenses | 25.72% | 19.81% | 0.63% | 7.95% | 6.27% |
| Depreciation & Amortization | -4.08% | 2.67% | -3.46% | -22.56% | -9.82% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.83% | 22.90% | 2.82% | 7.67% | 6.46% |
| Operating Income | 231.78% | 45.41% | 81.14% | 1,375.00% | 2,277.78% |
| Income Before Tax | 109.16% | 13.24% | 36.50% | 63.50% | -154.27% |
| Income Tax Expenses | 126.77% | 121.99% | 119.15% | 375.00% | -62.13% |
| Earnings from Continuing Operations | 71.20% | -6.58% | 10.74% | 52.46% | -189.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 25.17% | -25.93% | -137.70% | -6,528.57% | -464.33% |
| Net Income | 62.21% | -13.78% | -2.64% | 35.47% | -204.59% |
| EBIT | 231.78% | 45.41% | 81.14% | 1,375.00% | 2,277.78% |
| EBITDA | 43.66% | 27.09% | 20.96% | 68.30% | 12.02% |
| EPS Basic | 61.54% | -13.16% | -2.00% | 35.42% | -204.00% |
| Normalized Basic EPS | 183.33% | 90.63% | 140.00% | 85.00% | -12.50% |
| EPS Diluted | 72.60% | -13.16% | 5.41% | 35.42% | -246.00% |
| Normalized Diluted EPS | 183.33% | 84.38% | 140.00% | 85.00% | -12.50% |
| Average Basic Shares Outstanding | 0.09% | 0.47% | -0.13% | 0.19% | 0.22% |
| Average Diluted Shares Outstanding | 3.31% | 2.62% | 1.15% | 0.19% | -0.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |